Ilika trading update & notice of results

IKA

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has provided updates on trading, Stereax® manufacturing, and Goliath product development, as well as notice of its full year results for the year ended 30 April 2022.

Trading Update for FY22

Trading for the year ended 30 April 2022 has been in line with management expectations. The Company expects to announce revenues of approximately £0.5m (2021: £2.3m), and an EBITDA loss of around £7.0m (2021: EBITDA loss of £2.3m). Cash and cash equivalents at the period end were £23.4m (30 April 2021: £9.7m).

Stereax Manufacturing Update and Trading Update for FY23

Further to the official opening in December 2021 of its manufacturing facility for Stereax miniature solid-state batteries for industrial wireless sensors and medical implants, Ilika has been progressing facility process qualification to the point where it is now substantially complete. As indicated in the Company’s Interim Results on 20 January 2022, product qualification has commenced, which involves production of initial batches of batteries and testing them against specification. Whilst a series of process optimisation cycles have been carried out to date, it is taking longer than previously anticipated to ensure that product batches reproducibly meet specification.

In terms of an update on Ilika’s pipeline, the demand from potential customers is now weighted predominantly towards miniature medical device applications. The demand for such applications starts with device prototyping, followed by pre-clinical and clinical trials before regulatory approval and mass market roll-out, which has a longer regulatory approval cycle than industrial sensors. Ilika will match production volumes to customer demand.

The shift in the weighting of customer demand towards medical device applications combined with the expectation of optimisation cycles continuing into H2 FY23, means the Company now expects commercial sales to commence at the end of that period, later than originally anticipated. A number of the potential applications for Stereax exceed the capacity of Ilika’s facility, which provides longer term opportunities for partnering and licensing.

Goliath Progress Update

Product development of Goliath, Ilika’s large format battery for electric vehicles and customer appliances, has continued to progress to schedule, with significant improvements achieved in energy density (providing the potential for lighter weight battery packs) and power density (key for rapid charging). Ilika continues to explore opportunities for closer collaboration with strategic partners interested in aligning their product roadmaps with Goliath.

Notice of Results

Ilika plc (LON IKA) expects to announce its full year results for the year ended 30 April 2022 on Wednesday 13 July 2022. 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika plc: ORKA Launch Opens New Commercial Opportunities for Goliath in Marine and Defence Markets (video)

Ilika CEO Graeme Purdy explains how ORKA could accelerate Goliath's commercialisation through underwater defence applications while maintaining the company's long-term electric vehicle strategy.

Ilika launches ORKA brand as it targets deep-sea battery demand

Ilika has launched ORKA for pressure-tolerant deep-sea batteries aimed at autonomous underwater vehicles and defence applications.

Ilika launches ORKA brand for deep-sea battery systems

ika has launched ORKA, a new brand for its pressure-tolerant batteries designed for autonomous underwater vehicles. The technology supports operations at depths of up to 6,000 metres and forms part of the company's strategy to commercialise its Goliath batteries in defence and other non-automotive markets.

Ilika to attend NANS 2027 in Las Vegas

Ilika will attend NANS 2027 in Las Vegas, engaging with the neuromodulation and medical technology sectors as it develops its Stereax solid-state batteries for medical devices.

Ilika targets earlier commercialisation opportunities for Goliath solid-state batteries

Ilika is pursuing defence and e-bike applications to accelerate commercial opportunities for its Goliath solid-state batteries while continuing development for the electric vehicle market.

Ilika’s Stereax batteries to be represented at MD&M Midwest 2026

Ilika's Stereax miniature solid-state batteries will be represented by Cirtec Medical at MD&M Midwest in Minneapolis as the company continues to develop medical device applications.

Search